Inspiring & original thinking. And, the latest news about us.
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
- Renalytix plc successful completion of $30.0 million financing package 04.08.22
- Renalytix plc Issue of shares 04.08.22
- Renalytix announces a $30.0 million financing package 03.31.22
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 03.31.22
- Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors 03.30.22
- Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes 03.29.22
- Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 03.25.22
- Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform 03.09.22
- KidneyIntelX™ Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care 02.24.22
- Renalytix to Present at Cowen 42nd Annual Health Care Conference 02.22.22